Roberto Petrioli

4.2k total citations
135 papers, 3.1k citations indexed

About

Roberto Petrioli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Roberto Petrioli has authored 135 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 76 papers in Oncology and 28 papers in Surgery. Recurrent topics in Roberto Petrioli's work include Prostate Cancer Treatment and Research (29 papers), Gastric Cancer Management and Outcomes (28 papers) and Colorectal Cancer Treatments and Studies (27 papers). Roberto Petrioli is often cited by papers focused on Prostate Cancer Treatment and Research (29 papers), Gastric Cancer Management and Outcomes (28 papers) and Colorectal Cancer Treatments and Studies (27 papers). Roberto Petrioli collaborates with scholars based in Italy, United States and United Kingdom. Roberto Petrioli's co-authors include Guido Francini, Giandomenico Roviello, Franco Roviello, Edoardo Francini, Daniele Marrelli, Stefania Marsili, Karol Połom, Luigi Marano, Daniele Generali and Anna Ida Fiaschi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Roberto Petrioli

130 papers receiving 3.0k citations

Peers

Countries citing papers authored by Roberto Petrioli

Since Specialization

Citations

This map shows the geographic impact of Roberto Petrioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Petrioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Petrioli more than expected).

Fields of papers citing papers by Roberto Petrioli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Petrioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Petrioli. The network helps show where Roberto Petrioli may publish in the future.

Co-authorship network of co-authors of Roberto Petrioli

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Petrioli. A scholar is included among the top collaborators of Roberto Petrioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Petrioli. Roberto Petrioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival 2021 ·European Journal of Surgical Oncology ·Franco Roviello, Luigi Marano, Maria Raffaella Ambrosio, (unknown), Alessia D’Ignazio, (unknown), Roberto Petrioli, (unknown), Karol Połom, Raffaele Macchiarelli, (unknown), Daniele Marrelli	22
2	FOLFOX vs FOLFIRI as Second-line of Therapy After Progression to Gemcitabine/Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer 2020 ·SHILAP Revista de lepidopterología ·Martina Catalano, Raffaele Conca, Roberto Petrioli, (unknown), Giandomenico Roviello	1
3	Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel 2019 ·Anti-Cancer Drugs ·Giandomenico Roviello, Silvia Paola Corona, (unknown), Roberto Petrioli, (unknown), Michele Aieta	2
4	The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer 2019 ·Investigational New Drugs ·Giandomenico Roviello, Roberto Petrioli, (unknown), (unknown), Raffaele Conca, (unknown), (unknown), Michele Aieta	2
5	Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer 2018 ·Medicine ·Giandomenico Roviello, Roberto Petrioli, Valerio Nardone, (unknown), (unknown), Raffaele Conca, Michele Aieta	9
6	Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 2018 ·Clinical Colorectal Cancer ·Roberto Petrioli, (unknown), (unknown), Anna Ida Fiaschi, Vinno Savelli, Ignazio Martellucci, Edoardo Francini	22
7	Reduced Dose of Abiraterone Acetate with Concomitant Low-dose Prednisone in the Treatment of ≥ 85 Year-old Patients with Advanced Castrate-resistant Prostate Cancer. 2015 ·PubMed ·Roberto Petrioli, Edoardo Francini, Anna Ida Fiaschi, Letizia Laera, (unknown), (unknown), Giandomenico Roviello	6
8	Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer 2015 ·Clinical Genitourinary Cancer ·Roberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, Letizia Laera, Vincenzo Bianco, Roberto Ponchietti, Gabriele Barbanti, Edoardo Francini	6
9	Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer 2015 ·Anti-Cancer Drugs ·Roberto Petrioli, Giandomenico Roviello, Anna Ida Fiaschi, Letizia Laera, (unknown), Vincenzo Bianco, Edoardo Francini	1
10	Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 2015 ·Tumor Biology ·Giandomenico Roviello, Karol Połom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, (unknown), Vinno Savelli, Daniele Generali, Lorenzo De Franco, Andrea Ravelli, Franco Roviello	10
11	Targeted Therapies for Prostate Cancer 2015 ·Cancer Investigation ·Roberto Petrioli, Edoardo Francini, Anna Ida Fiaschi, Letizia Laera, Giandomenico Roviello	6
12	Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma 2011 ·Annals of Oncology ·Matthew D. Galsky, (unknown), William Oh, Joaquim Bellmunt, Bruce J. Roth, Roberto Petrioli, Luigi Dogliotti, Robert Dreicer, Guru Sonpavde	210
13	Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab 2011 ·The Journal of the American Dental Association ·(unknown), (unknown), Edoardo Francini, (unknown), (unknown), (unknown), Roberto Petrioli	23
14	The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer 2008 ·European Journal of Internal Medicine ·A Montagnani, S. Gonnelli, A. Cadirni, Carlo Caffarelli, (unknown), (unknown), Maria Stella Campagna, (unknown), Roberto Petrioli, Ranuccio Nuti	21
15	Antiphospholipid antibodies and acute-phase response in non-metastatic colorectal cancer patients 2008 ·The International Journal of Biological Markers ·(unknown), (unknown), Roberto Petrioli, (unknown), (unknown), Gabriele Donati, Vittoria Vittoria, Franco Roviello	7
16	Treatment of colon and breast carcinoma cells with 5‐fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA‐A()02.01 restricted, CEA‐peptide‐specific cytotoxic T cells in vitro* 2003 ·International Journal of Cancer ·Pierpaolo Correale, Angelo Aquino, Antonio Giuliani, (unknown), Lucia Micheli, Maria Grazia Cusi, Cristina Nencini, Roberto Petrioli, Salvatore Pasquale Prete, Liana De Vecchis, Mario Turriziani, Giorgio Giorgi, Enzo Bonmassar, Guido Francini	72
17	Weekly Low-Dose Docetaxel in Advanced Hormone-Resistant Prostate Cancer Patients Previously Exposed to Chemotherapy 2003 ·Oncology ·Roberto Petrioli, Daniele Pozzessere, (unknown), Marianna Sabatino, (unknown), Stefania Marsili, Pierpaolo Correale, Antonio Manganelli, Francesco Salvestrini, Guido Francini	24
18	High-Affinity HLA-A()02.01 Peptides from Parathyroid Hormone-Related Protein Generate In Vitro and In Vivo Antitumor CTL Response Without Autoimmune Side Effects 2002 ·The Journal of Immunology* ·Guido Francini, Antonio Scardino, Kostas Kosmatopoulos, François A. Lemonnier, (unknown), Marianna Sabatino, Daniele Pozzessere, Roberto Petrioli, Luisa Lozzi, Paolo Neri, Giuseppe Fanetti, Maria Grazia Cusi, Pierpaolo Correale	30
19	Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients: A randomized phase II study 1996 ·Cancer ·Roberto Petrioli, Bruno Frediani, Antonio Manganelli, Gabriele Barbanti, Bruno De Capua, (unknown), (unknown), Sergio Mondillo, Guido Francini	122
20	Weekly chemotherapy in advanced prostatic cancer 1993 ·British Journal of Cancer ·Guido Francini, Roberto Petrioli, A Manganelli, Marcella Cintorino, Stefania Marsili, (unknown), Sergio Mondillo	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact